Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Technological advances that enhance gene expression
3.2.1.2 Growing adoption of personalized medicine
3.2.1.3 High investment in genomic research
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of the instruments
3.2.2.2 Lack of skilled labor
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Process, 2018 – 2032 ($ Million)
5.1 Key trends
5.2 Sample collection
5.3 Purification
5.4 cDNA synthesis & conversion
5.5 PCR analysis
5.6 Data analysis & interpretation
Chapter 6 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Million)
6.1 Key trends
6.2 Consumables
6.2.1 Reagents
6.2.2 DNA chips
6.3 Instruments
6.3.1 PCR
6.3.2 NGS
6.3.3 DNA microarray
6.3.4 Other instruments
6.4 Services
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Million)
7.1 Key trends
7.2 Drug discovery & development
7.3 Clinical diagnostics
7.4 Biotech & microbiology
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By Technique, 2018 – 2032 ($ Million)
8.1 Key trends
8.2 RNA expression
8.3 Promoter analysis
8.4 Protein expression & posttranslational modification analysis
Chapter 9 Market Estimates and Forecast, By Capacity, 2018 – 2032 ($ Million)
9.1 Key trends
9.2 Low- to mid- plex
9.3 High-plex
Chapter 10 Market Estimates and Forecast, By End-User, 2018 – 2032 ($ Million)
10.1 Key trends
10.2 Pharmaceutical and biotechnology companies
10.3 Diagnostic laboratories
10.4 Academic research centers
Chapter 11 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Million)
11.1 Key trends, by region
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Agilent Technologies, Inc.
12.2 Bio-Rad Laboratories, Inc.
12.3 F. Hoffmann-La Roche Ltd.
12.4 GE HealthCare Technologies, Inc.
12.5 Illumina, Inc.
12.6 Oxford Nanopore Technologies Plc.
12.7 Pacific Biosciences of California, Inc.
12.8 PerkinElmer, Inc.
12.9 Promega Corporation
12.10 Qiagen N.V.
12.11 Thermo Fisher Scientific Inc.
